Major pharmaceutical companies have embarked on historic capital build-outs (totaling tens of billions) to enlarge production of GLP-1 APIs and formulations ( [5] ) ( [23] )
Minimize air exposure to reduce oxidation risks
The different CRP isoforms, nCRP, non-native pentameric CRP (nnCRP) and mCRP (175178, 181184), may explain their protective and destructive effects, with nCRP being primarily antiinflammatory inducing Th2/M2 responses, while mCRP being typically proinflammatory inducing Th1/M1 responses (170, 185189)
Once the trials are complete, its expected that retatrutide could receive FDA approval in the near future
Semaglutide, the blockbuster GLP-1 receptor agonist marketed under names like Ozempic (type 2 diabetes) and Wegovy (weight loss), has rapidly become one of the most consequential drugs in modern healthcare